The final rule is sure to shake up the diagnostic industry, for better or worse, depending on who you talk to.

The deal comes during a time when M&A is becoming more prevalent in the medtech industry.

In part 1 of MD+DI’s interview with Jim O’Connell, he highlights the integration process of Hillrom into Baxter as the acquisition marks two years.

First-of-its-kind, Esprit BTK Everolimus Eluting Resorbable Scaffold System is designed to keep treat chronic limb-threatening ischemia below the knee and deliver Everolimus to support vessel healing through a stent that dissolves over time.

The company said it would pay $1.1 billion to settle claims over its recalled Respironics devices.

Upgrades to a recently acquired moldmaking shop in Denmark include 5-axis laser texturing and high-speed milling as well as automated handling systems.